UiPath Inc. (PATH) closed at $11.55 on 05 Mar 2026, up 4.34% as traders price in an upcoming earnings report scheduled for 11 Mar 2026. PATH stock moves today came on 32,963,956 shares traded versus an average of 29,225,291, reflecting higher interest ahead of the results. Investors will watch ARR growth, revenue guidance and margin progress to decide if recent gains can hold into next week.

PATH stock: Earnings calendar and what to watch

UiPath reports on 11 Mar 2026 (after the U.S. close). The company’s last quarter showed revenue of $411.11 million and EPS of $0.16, which beat estimates. Analysts and investors will focus on revenue growth, subscription ARR, and management guidance for the next quarter.

Watch guidance for FY and quarterly ARR acceleration, plus commentary on competition from new AI copilots. The market will also parse FY margins and any commentary on deal durations or pricing changes.

PATH stock: Key financials and valuation metrics

UiPath shows trailing EPS $0.42 and a trailing P/E of 27.51 with market cap USD 6.18 billion. Price-to-sales is 3.98 and price-to-book is 3.23, signaling a premium to some software peers. The company has cash per share $2.59, low net debt, and a current ratio of 2.54.

Revenue growth remains a central metric: FY revenue growth was 23.57% year over year in the latest filing. Gross margin is strong at 83.16%, but operating margin is thin; expect management commentary on operating leverage after past investments.

PATH stock: Technical setup and trading signals

Technically, PATH stock closed the session above the prior close at $11.55, with a day range $11.07–$11.80 and 50-day average $13.78. RSI sits near 45.89, MACD histogram is turning positive, and ADX at 35.87 denotes a strong trend environment.

Volume today at 32.96M exceeded the 3-month average of 29.23M, showing elevated participation. Key levels to monitor are $9.38 (52-week low), $13.00–$14.00 resistance zone, and $11.00 support near recent lows.

PATH stock: Analyst views and market sentiment

Wall Street consensus leans neutral: MarketBeat lists an average target of $15.77 and most analysts rate PATH as Hold. Recent targets range from $12.00 to $18.00, with BMO and Barclays among the firms lifting targets to the mid-teens.

Insiders have sold shares recently; institutional ownership is 62.50%. That mix keeps sentiment balanced into earnings and suggests upside requires clear signs of durable ARR momentum.

PATH stock: Meyka AI grade and valuation context

Meyka AI rates PATH with a score out of 100: 76.14, Grade B+, Suggestion BUY. This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational and not financial advice.

Valuation shows EV/Sales 3.54 and free cash flow yield 5.04%. Given UiPath’s strong gross margin and low net debt, the grade reflects a balance between growth prospects and elevated multiples versus peers.

PATH stock: Risks and opportunities into earnings

Opportunities include continued ARR expansion and operating leverage if subscription growth accelerates. UiPath’s platform strength in RPA and expanding AI features can drive multi-year adoption across banking, healthcare and government.

Risks include competitive pressure from new generative AI products, elongated sales cycles (days sales outstanding 116.59) and recent insider selling. Watch guidance for signs of cadence change or softer billings that could pressure the shares.

Final Thoughts

PATH stock sits at $11.55 on the NYSE as investors position for the 11 Mar 2026 earnings report. Key drivers will be ARR growth, revenue guidance and margin improvement. Meyka AI’s forecast model projects a yearly target of USD 15.48, which implies an upside of 33.99% versus the current price of USD 11.55. Short-term stresses exist: 50-day average USD 13.78, PE about 27.51, and elevated days sales outstanding. Analysts’ average target is USD 15.77, while bullish desks range up to USD 18.00. The coming report can validate the premium valuation if management shows sustained ARR momentum and clearer operating leverage. For traders, watch volume, guidance tone, and ARR cadence. For longer-term investors, the balance of strong gross margins, low net debt and platform adoption supports the Meyka AI B+ rating, but the stock will remain sensitive to quarterly guidance and AI-competitive headlines. For more on metrics and live updates, see Meyka AI’s platform and the company filings. Meyka AI is an AI-powered market analysis platform and provides model-based projections; forecasts are projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.